共 50 条
Getting better mileage with logically primed CARs
被引:2
|作者:
Chen, Laurence C.
[1
]
Hou, Andrew J.
[1
]
Chen, Yvonne Y.
[1
,2
,3
]
机构:
[1] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Parker Inst Canc Immunotherapy Ctr, Los Angeles, CA 90095 USA
来源:
基金:
美国国家科学基金会;
关键词:
CELLS;
D O I:
10.1016/j.medj.2021.06.002
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Although remarkably successful against liquid tumors, chimeric anti-gen receptor (CAR)-T cell therapy has been stymied by solid tumors, limited by inadequate specificity and poor efficacy. Pairing synthetic Notch (synNotch) receptors with CARs, Choe et al. and Hyrenius-Wittsten et al. engineer T cells that more precisely and potently combat solid tumors.
引用
收藏
页码:785 / 787
页数:3
相关论文